Schering-Plough Reschedules Time of Conference Call, Webcast for 2008 Second Quarter Earnings to Later Today

... KENILWORTH N.J. July 21 /- Schering-Ploug...Schering-Plough made the second-quarter earnings schedule changebecau...To listen live to the Schering-Plough second quarter earningsconferen...Schering-Plough is an innovation-driven science-centered global healt...

KENILWORTH, N.J., July 21 /PRNewswire-FirstCall/ -- Schering-Plough
Corporation (NYSE: SGP) has rescheduled the time of its conference call and
webcast to review the sales and earnings results for the 2008 second
quarter to approximately 4:45 p.m. (EDT) from 8 a.m. today. The quarterly
financial results will be issued today, July 21, 2008, after the close of
the New York Stock Exchange.

Schering-Plough made the second-quarter earnings schedule change
because Terje Pedersen, M.D., Ph.D., Chief, Preventive Medicine Clinic,
Ulleval University Hospital, Oslo, Norway, and the primary investigator of
Simvastatin plus Ezetimibe in Aortic Stenosis study (SEAS), has announced
that he will present an update on the study at 1 p.m. (U.S. EDT) today.

To listen live to the Schering-Plough second quarter earnings
conference call, dial 1-877-565-9664 or 1-706-634-5003 and enter conference
ID #50992673. A replay of the call will be available beginning later on
July 21 through 5 p.m. on July 28. To listen to the replay, dial
1-800-642-1687 or 1-706-645-9291 and enter the conference ID #50992673. A
live audio webcast of the conference call also will be available by going
to the Investor Relations section of the Schering-Plough corporate Web
site, http://www.schering-plough.com, and clicking on the "Presentations/Webcasts"
link. A replay of the webcast will be available starting on July 21 through
5 p.m. on Aug. 20.

Schering-Plough is an innovation-driven, science-centered global health
care company. Through its own biopharmaceutical research and collaborations
with partners, Schering-Plough creates therapies that help save and improve
lives around the world. The company applies its research-and-development
platform to human prescription and consumer products as well as to animal
health products. Schering-Plough's vision is to "Earn Trust, Every Day"
with the doctors, patients, customers and other stakeholders served by its
colleagues around the world. The company is based in Kenilworth, N.J., and
its Web site is http://www.schering-plough.com.

(Date:10/12/2017)... ... October 12, 2017 , ... ... announced today that they have entered into a multiyear collaboration to identify and ... researchers with additional tools for gene editing across all applications. , Under the ...

(Date:10/12/2017)... ... October 12, 2017 , ... ... genomics analysis platform specifically designed for life science researchers to analyze and ... researcher Rosalind Franklin, who made a major contribution to the discovery of ...